Bristol-Myers Squibb (NYSE:BMY) had it drug Yervoy approved by the Food and Drug Administration on Friday, the first drug that has been effective in prolonging the lives of people with the skin cancer melanoma
“This is really the first time in the melanoma field that there is a drug that extended survival in a meaningful way,” said Dr. Gerald P. Linette, an assistant professor of medicine at Washington University in St. Louis, cited by the New York Times.
The Times added, "In a randomized clinical trial, patients with metastatic melanoma treated with Yervoy lived a median of about 10 months, compared with 6.4 months for patients in a control group, who received a treatment believed to have had little effect.
"After two years, more than 20 percent of those who got Yervoy, also known as ipilimumab, were alive, compared with 13.7 percent for the control group.
"Bristol-Myers said it would charge $120,000 for a complete course of treatment, which consists of four infusions given over a three-month period.
"There were about 68,000 new cases of melanoma in the United States last year and 8,700 deaths, according to the American Cancer Society. The number of cases has been rising, probably because of sun exposure without proper protection at a younger age."
Bristol-Myers was trading at $27.42, gaining $0.99, or 3.75 percent, as of 2:40 PM EDT.
Source
Showing posts with label Food and Drug Administration. Show all posts
Showing posts with label Food and Drug Administration. Show all posts
Friday, March 25, 2011
Bristol-Myers (BMY) Melanoma Drug Approved
Labels:
Bristol-Meyers,
FDA,
Food and Drug Administration,
Melanoma
Monday, August 16, 2010
LA. Shrimpers Begin Harvesting, BP (NYSE:BP) Oil Still A Concern
Shrimpers have returned to Louisiana to begin their harvesting season, but there are still concerns about the BP (NYSE:BP) oil that may have effected the shrimp. They are not for sure the price they will get if consumers are concerned about contamination, among other possible effects.
The massive oil spill has effected fishing as a whole in a state that ranks first for its shrimp, oysters, blue crab, and craw fish. It's a $318 million industry in Louisiana annually. Fisherman have already seen the prices crash in the Summer by scared consumers who stopped purchasing their products.
The biggest fear is that fisherman may try and sell oily seafood. A shrimper from Buras, Dewayne Bayham said, "If you see oil shrimp you got to throw them back over. Go somewhere else. It's all you can do, and you hope everyone else does the same."
On Friday, several fisherman did a test run around Grand Isle and Barataria Bay. Several areas were tralled and than the nets were pulled up revealing shrimp, jellyfish, mud, and driftwood. None of which contained any smell of oil. To reopen harvesting, the Food and Drug Administration has set levels which have to test below 12 various potential cancer causing substances.
The massive oil spill has effected fishing as a whole in a state that ranks first for its shrimp, oysters, blue crab, and craw fish. It's a $318 million industry in Louisiana annually. Fisherman have already seen the prices crash in the Summer by scared consumers who stopped purchasing their products.
The biggest fear is that fisherman may try and sell oily seafood. A shrimper from Buras, Dewayne Bayham said, "If you see oil shrimp you got to throw them back over. Go somewhere else. It's all you can do, and you hope everyone else does the same."
On Friday, several fisherman did a test run around Grand Isle and Barataria Bay. Several areas were tralled and than the nets were pulled up revealing shrimp, jellyfish, mud, and driftwood. None of which contained any smell of oil. To reopen harvesting, the Food and Drug Administration has set levels which have to test below 12 various potential cancer causing substances.
Subscribe to:
Posts (Atom)